Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

US Patent 11590117 · Granted Feb 28, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating multiple myeloma and the use of companion biomarkers for 4-2025
Methods for treating multiple myeloma and the use of companion biomarkers for 4-2025
Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and2025
Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other c2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Ionospheric disturbance information generation methods and systems2025
Communication station, optical communication system, data transmission method, a2025
Methods and combinations for treatment and T cell modulation2025
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024